A comprehensive review of the prevalence of beta globin gene variations and the co-inheritance of related gene variants in Saudi Arabians with beta-thalassemia

References

1. ↵
   1. Quek L,
   2. Thein SL

   (2007) Molecular therapies in -thalassaemia. Br J Haematol 136:353–365.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   1. Borgio JF,
   2. Al-Madan MS,
   3. AbdulAzeez S

   (2016) Mutation near the binding interfaces at -hemoglobin stabilizing protein is highly pathogenic. Am J Transl Res 8:4224.

   OpenUrl
3. ↵
   1. Feng L,
   2. Gell DA,
   3. Zhou S,
   4. Gu L,
   5. Kong Y,
   6. Li J,
   7. et al.

   (2004) Molecular mechanism of AHSP-mediated stabilization of -hemoglobin. Cell 119:629–640.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. El-Hazmi MA,
   2. Warsy AS

   (1999) Appraisal of sickle-cell and thalassaemia genes in Saudi Arabia. East Mediterr Health J 5:1147–1153.

   OpenUrlPubMed
5. 1. Memish ZA,
   2. Saeedi MY

   (2011) Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and -thalassemia in Saudi Arabia. Ann Saudi Med 31:229.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Ministry of Health

   Premarital Screening, Available from: https://www.moh.gov.sa/en/healthawareness/beforemarriage/Pages/default.aspx. [Accessed 2017 June 15th].
7. ↵
   1. Al-Abdulkareem AA,
   2. Ballal SG

   (1998) Consanguineous marriage in an urban area of Saudi Arabia: rates and adverse health effects on the offspring. J Community Health 23:75–83.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Memish ZA,
   2. Owaidah TM,
   3. Saeedi MY

   (2011) Marked regional variations in the prevalence of sickle cell disease and -thalassemia in Saudi Arabia: findings from the premarital screening and genetic counseling program. J Epidemiol Glob Health 1:61–68.

   OpenUrl
9. ↵
   1. Carley A

   (2003) Anemia: when is it not iron deficiency? Pediatr Nurs 29:205.

   OpenUrlPubMed
10. ↵
    1. Al-Awamy BH

    (2000) Thalassemia syndromes in Saudi Arabia. Meta-analysis of local studies. Saudi Med J 21:8–17.

    OpenUrlPubMed
11. ↵
    1. Mosca A,
    2. Paleari R,
    3. Ivaldi G,
    4. Galanello R,
    5. Giordano PC

    (2009) The role of haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies. J Clin Pathol 62:13–17.

    OpenUrlAbstract/FREE Full Text
12. ↵
    1. El-Hazmi MA,
    2. Al-Swailem AR,
    3. Warsy AS

    (1995) Molecular Defects in Beta-Thalassaemia in the Population of Saudi Arabia. Hum Hered 45:278–285.

    OpenUrlPubMed
13. ↵
    1. El-Hazmi MA,
    2. Warsy AS,
    3. Al-Swailem AR

    (1995) The frequency of 14 -thalassemia mutations in the Arab populations. Hemoglobin 19:353–360.

    OpenUrlPubMed
14. ↵
    1. El-Harith EH,
    2. KÜhnau W,
    3. Schmidtke J,
    4. Stuhrmann M,
    5. Nasserallah Z,
    6. Al-shahri A

    (1999) Identification and clinical presentation of thalassaemia mutations in the eastern region of Saudi Arabia. J Med Genet 36:936–937.

    OpenUrl
15. ↵
    1. Borgio JF,
    2. AbdulAzeez S,
    3. Naserullah ZA,
    4. Al-Jarrash S,
    5. Al-Ali RA,
    6. Al-Madan MS,
    7. et al.

    (2016) Mutations in the -globin gene from a Saudi population: an update. Int J Lab Hematol, 38.
16. ↵
    1. Al-Ali AK,
    2. Al-Ateeq S,
    3. Imamwerdi BW,
    4. Al-Sowayan S,
    5. Al-Madan M,
    6. Al-Muhanna F,
    7. et al.

    (2005) Molecular bases of -thalassemia in the Eastern Province of Saudi Arabia. J Biomed Biotechnol 2005:322–325.

    OpenUrlPubMed
17. ↵
    1. Al-Sultan A,
    2. Phanasgaonkar S,
    3. Suliman A,
    4. Al-Baqushi M,
    5. Nasrullah Z,
    6. Al-Ali A

    (2011) Spectrum of -thalassemia mutations in the eastern province of Saudi Arabia. Hemoglobin 35:125–134.

    OpenUrl
18. ↵
    1. Akhtar MS,
    2. Qaw F,
    3. Borgio JF,
    4. Albuali W,
    5. Suliman A,
    6. Nasserullah Z,
    7. Al-Jarrash S,
    8. Al-Ali A

    (2013) Spectrum of -thalassemia mutations in transfusion-dependent -thalassemia patients from the Eastern Province of Saudi Arabia. Hemoglobin 37:65–73.

    OpenUrl
19. ↵
    1. Al-Nafie AN,
    2. Borgio JF,
    3. AbdulAzeez S,
    4. Al-Suliman AM,
    5. Qaw FS,
    6. Naserullah ZA,
    7. et al.

    (2015) Co-inheritance of novel ATRX gene mutation and globin (& gene mutations in transfusion dependent beta-thalassemia patients. Blood Cells Mol Dis 55:27–29.

    OpenUrl
20. ↵
    1. Borgio JF

    (2015) Molecular nature of alpha-globin genes in the Saudi population. Saudi Med J 36:1271.

    OpenUrlAbstract/FREE Full Text
21. ↵
    1. Patrinos GP,
    2. Giardine B,
    3. Riemer C,
    4. Miller W,
    5. Chui DH,
    6. Anagnou NP,
    7. et al.

    (2004) Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res 32:537–541.

    OpenUrl
22. ↵
    1. Giardine B,
    2. van Baal S,
    3. Kaimakis P,
    4. Riemer C,
    5. Miller W,
    6. Samara M,
    7. et al.

    (2007) HbVar database of human hemoglobin variants and thalassemia mutations:2007 update. Hum Mutat 28:206.

    OpenUrlPubMed
23. ↵
    1. Boehm CD,
    2. Dowling CE,
    3. Waber PG,
    4. Giardina PJ,
    5. Kazazian HJ

    (1986) Use of oligonucleotide hybridization in the characterization of a beta zero-thalassemia gene (beta 37 TGG----TGA) in a Saudi Arabian family. Blood 67:1185–1188.

    OpenUrlAbstract/FREE Full Text
24. ↵
    1. Wong C,
    2. Antonarakis SE,
    3. Goff SC,
    4. Orkin SH,
    5. Forget BG,
    6. Nathan DG,
    7. et al.

    (1989) Beta-thalassemia due to two novel nucleotide substitutions in consensus acceptor splice sequences of the beta-globin gene. Blood 73:914–918.

    OpenUrlAbstract/FREE Full Text
25. ↵
    1. Ahmed M,
    2. Stuhrmann M,
    3. Bashawri L,
    4. Kühnau W,
    5. El-Harith EH

    (2001) The -globin genotype E121Q/W15X (cd121GAA®CAA/cd15TGG®TGA) underlines Hb D/ -(0) thalassaemia marked by domination of haemoglobin D. Ann Hematol 80:629–633.

    OpenUrlPubMed
26. ↵
    1. Abuzenadah AM,
    2. Hussein IM,
    3. Damanhouri GA,
    4. A-Sayes FM,
    5. Gari MA,
    6. Chaudhary AG,
    7. et al.

    (2011) Molecular basis of -thalassemia in the western province of Saudi Arabia: Identification of rare -thalassemia mutations. Hemoglobin 35:346–357.

    OpenUrl
27. 1. Warsy AS,
    2. El-Hazmi MA,
    3. Aleem A,
    4. Al-Hazmi AM,
    5. Al-Momin AK

    (2012) Genetic basis of Saudi beta thalassemia identification of Mediterranean and Asian Mutations. Biosci Biotech Res Asia 9:97–104.

    OpenUrl
28. ↵
    1. Borgio JF,
    2. AbdulAzeez S,
    3. Al-Nafie AN,
    4. Naserullah ZA,
    5. Al-Jarrash S,
    6. Al-Madan MS,
    7. et al.

    (2014) A novel HBA2 gene conversion in cis or trans: “12 allele” in a Saudi population. Blood Cells Mol Dis 53:199–203.

    OpenUrl
29. ↵
    1. Thein SL

    (2013) The molecular basis of -thalassemia. Cold Spring Harb Perspect Med 3:a011700.

    OpenUrlAbstract/FREE Full Text
30. ↵
    1. Borgio JF,
    2. AbdulAzeez S,
    3. Al-Muslami AM,
    4. Naserullah ZA,
    5. Al-Jarrash S,
    6. Al-Suliman AM,
    7. et al.

    (2018) KLF1 gene and borderline hemoglobin A2 in Saudi population. Arch Med Sci 14:230.

    OpenUrl
31. ↵
    1. Al-Amodi AM,
    2. Ghanem NZ,
    3. Aldakeel SA,
    4. Ibrahim Al Asoom L,
    5. Rafique Ahmed N,
    6. Almandil NB,
    7. et al.

    (2018) Hemoglobin A2 (HbA2) has a measure of unreliability in diagnosing -thalassemia trait (-TT). Curr Med Res Opin 15:1–7.

    OpenUrl